Dr. David Shlaes has been following the various discussions around the development of rapid diagnostic tests for acute bacterial infections. The ACSH advisor has concluded that broad-spectrum empiric therapy of potentially serious infections in the hospital will continue – and well it should – regardless of the availability of such rapid tests.
